A 24-Week, Randomized, Controlled Study to Evaluate the Tolerability, Safety and Efficacy of 2 Different Titration Schemes of the Rivastigmine Patch in Japanese Patients with Mild to Moderate Alzheimer's Disease

Yu Nakamura, Akira Homma, Kaoru Tamura et al.|Dementia and Geriatric Cognitive Disorders Extra|2015

Cited by 11